Although CD44+CD24+ and CD44+CD54+ cells have clinical relevance in patients with GC, it is still necessary to determine whether these cells with self-renewal capability are true gastric cancer stem cells (GCSCs). This evidence concerns the gene CD24 and gastric cancer.